INTRACAVITARY DEVICE IMPROVING GENITOURINARY SYNDROME AND THE APPEARANCE OF THE VULVA.

Rodríguez Lastra J1, García Y2

Research Type

Clinical

Abstract Category

Female Sexual Dysfunction

Abstract 412
Open Discussion ePosters
Scientific Open Discussion Session 102
Wednesday 23rd October 2024
12:30 - 12:35 (ePoster Station 3)
Exhibition Hall
Female New Devices Rehabilitation Sexual Dysfunction Pain, Pelvic/Perineal
1. Universidad Alfonso X El Sabio, 2. INNEO Clinic Barcelona
Presenter
Links

Poster

Abstract

Hypothesis / aims of study
Gynecological pathologies affect a significant number of women both postpartum and cancer survivors. Usual rehabilitation, although it improves the symptoms, does not achieve all the desired effect. Energy device has been used for years and within these the Laser, the most studied option. However, new generation of TECAR, with a finger-shaped intracavitary device, temperature control in the area of the introitus, allows a greater amount of energy without injuries, is safely applied and temperature to be raised between 40 and 45 °C. This energy induces fibroblasts to produce collagen, activating heat shock proteins and initiation of inflammatory cascade. Increase vascular growth factors, generate new blood vessels, improved circulation, producing increased moisture and roughness of the walls of the vagina and epithelial growth factor improved the skin of the vulva. On the other hand, they release protons and electrons that block the Na+/Ka+ ATPase, producing pain relief
Study design, materials and methods
All patients were performed with the same procedure. The active plate placed on the mons pubis together with an intracavitary MJS device were applied. The treatment time was 12 minutes. In total, 100 women were studied, 22 with GSM 20 Vaginal atrophy and 53 patients with pain due to Endometriosis, 10 cases of vaginal rejuvenation are presented. VAS and the ICIQ Flux Sex questionnaire were administered to all of them.
Results
With 80%. Changes were found in the pain and strength variables, from 5.90 ± 3.98 to 1.30 ± 2.54, p = 0.002 and from 3.30 ± 1.49 to 4.80 ± 0.42, p = 0.005. 100% improves sexual satisfaction. And from 1.90 ± 0.99 to 4.10 ± 0.56, p = 0.000 for vaginal dryness, 2.17 ± 0.98 to 4.17 ± 0.40, p = 0.003 for laxity. Female Sexual Function Index goes an average of 3.2 to 4.9 (p = 0.002).
Interpretation of results
The high power 1200 Watts per channel that produces molecular movement and internal heat together with the electrical stimulation in the cell membrane increases the production of signals that reduce pain, strengthen muscles and regenerate tissue. Other authors have demonstrated these effects, using other types of energy in a longer period of time, with lesser results 33% of pain reduction and with side effects.
Concluding message
This treatment is harmless with immediate incorporation into daily activities. In all cases, an increase in the turgor of the labia and a better appearance of the vulva is observed. As well as an improvement in the feeling of well-being. Changes in the appearance of the vulva are maintained over time
Figure 1 Evolution of the image of the vulva after RF treatment and evolution up to one year
Figure 2 Evolution of the VAS scale in the patients studied
References
  1. Joris A, Di Pietrantonio V, Praet J, Renard K, Verduyn AC, Buxant F, Rozenberg S. Randomized trial: treatment of genitourinary syndrome of menopause using radiofrequency. Climacteric. 2024 Apr;27(2):210-214. doi: 10.1080/13697137.2024.2302425.
  2. Pinheiro, C., Costa, T., Amorim de Jesus, R. et al. Intravaginal nonablative radiofrequency in the treatment of genitourinary syndrome of menopause symptoms: a single-arm pilot study. BMC Women's Health 21, 379 (2021). https://doi.org/10.1186/s12905-021-01518-8
Disclosures
Funding Not have Grant or founding Clinical Trial No Subjects Human
25/04/2025 09:57:18